PLx Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PLx Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26873% to $8,208,000. Profit margin reached -627%. Total operating expenses were $44,193,000.

Profit Margin

PLx Pharma Inc. (NASDAQ:PLXP): Profit margin
2012 0 -1.84M
2013 0 -4.01M
2014 0 -13.58M
2015 0 -18.74M
2016 0 -21.32M
2017 778.65K -15.34M -1970.92%
2018 753.10K 896.48K 119.04%
2019 565.46K -21.33M -3773.74%
2020 30.43K -15.10M -49631.91%
2021 8.20M -51.46M -626.95%

PLXP Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
8.20M30.43K565.46K753.10K778.65K00000
Cost of revenue
4.80M000000000
Gross profit
3.40M30.43K565.46K753.10K778.65K00000
Operating exp.
Research and development
4.18M4.33M4.74M3.92M4.15M12.75M11.28M8.89M1.72M844.63K
Selling and marketing
0000000000
Total operating expenses
44.19M13.48M14.76M11.71M14.33M21.36M18.76M13.58M4.01M1.84M
Operating income
-40.79M-13.45M-14.20M-10.96M-15.84M-21.36M-18.76M-13.58M-4.01M-1.84M
Other income (expenses), net
-5.33M-1.75M-6.30M11.85M-418.88K46.76K22.05K000
Income before tax
-46.12M-15.21M-20.50M896.48K-16.26M-21.32M-18.74M-13.58M-4.01M-1.84M
Income tax expense
5.33M-107.66K836.72K13.00M-920K00000
Net income
-51.46M-15.10M-21.33M896.48K-15.34M-21.32M-18.74M-13.58M-4.01M-1.84M
Earnings per share
Basic EPS
-2.18-1.55-2.390.1-2.19-16.45-15.9-13.84-6.94-3.6
Diluted EPS
-2.18-1.55-2.390.1-2.19-16.45-15.9-13.84-6.94-3.6
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source